{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T16:30:17Z","timestamp":1793205017949,"version":"4.5.0"},"reference-count":260,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T00:00:00Z","timestamp":1727136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biotechnology Advances"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.biotechadv.2024.108456","type":"journal-article","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T16:12:53Z","timestamp":1727194373000},"page":"108456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Bioengineered heparin: Advances in production technology"],"prefix":"10.1016","volume":"77","author":[{"given":"Razia","family":"Sultana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamichi","family":"Kamihira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biotechadv.2024.108456_bb0005","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.carbpol.2013.05.046","article-title":"Ultrasonic-assisted preparation of a low molecular weight heparin (LMWH) with anticoagulant activity","volume":"97","author":"Achour","year":"2013","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0015","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.2217\/nnm-2017-0127","article-title":"Heparin: new life for an old drug","volume":"12","author":"Al\u00e1ez-Vers\u00f3n","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biotechadv.2024.108456_bb0020","doi-asserted-by":"crossref","DOI":"10.1177\/10760296211052293","article-title":"General considerations for diversifying heparin drug products by improving the current heparin manufacturing process and reintroducing bovine sourced heparin to the US market","volume":"27","author":"Al-Hakim","year":"2021","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0025","doi-asserted-by":"crossref","first-page":"12678","DOI":"10.1073\/pnas.0504604102","article-title":"Tuning genetic control through promoter engineering","volume":"102","author":"Alper","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0030","doi-asserted-by":"crossref","first-page":"7535","DOI":"10.1007\/s00253-017-8511-2","article-title":"Chemoenzymatic synthesis of 3\u2032-phosphoadenosine-5\u2032-phosphosulfate coupling with an ATP regeneration system","volume":"101","author":"An","year":"2017","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0035","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.3390\/molecules25184215","article-title":"Heparan sulfate proteoglycans biosynthesis and post synthesis mechanisms combine few enzymes and few core proteins to generate extensive structural and functional diversity","volume":"25","author":"Annaval","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.biotechadv.2024.108456_bb0040","doi-asserted-by":"crossref","first-page":"6723","DOI":"10.1021\/bi00344a063","article-title":"Contribution of monosaccharide residues in heparin binding to antithrombin III","volume":"24","author":"Atha","year":"1985","journal-title":"Biochem"},{"key":"10.1016\/j.biotechadv.2024.108456_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159739","article-title":"Synthetic site-selectively mono-6-O-sulfated heparan sulfate dodecasaccharide shows anti-angiogenic properties in vitro and sensitizes tumors to cisplatin in vivo","volume":"11","author":"Avizienyte","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.biotechadv.2024.108456_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13568-020-01084-6","article-title":"N-glycolyl chondroitin synthesis using metabolically engineered E. coli","volume":"10","author":"Awofiranye","year":"2020","journal-title":"AMB Express"},{"key":"10.1016\/j.biotechadv.2024.108456_bb0055","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ymben.2012.01.008","article-title":"Metabolic engineering of Chinese hamster ovary cells: towards a bioengineered heparin","volume":"14","author":"Baik","year":"2012","journal-title":"Metab. Eng."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0060","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4161\/bioe.20902","article-title":"Toward a bioengineered heparin: challenges and strategies for metabolic engineering of mammalian cells","volume":"3","author":"Baik","year":"2012","journal-title":"Bioengineered"},{"key":"10.1016\/j.biotechadv.2024.108456_bb0065","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/biot.201400665","article-title":"Optimization of bioprocess conditions improves production of a CHO cell-derived, bioengineered heparin","volume":"10","author":"Baik","year":"2015","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0070","doi-asserted-by":"crossref","first-page":"10771","DOI":"10.1007\/s00253-015-6911-8","article-title":"Hydrolysis of by-product adenosine diphosphate from 3\u2032-phosphoadenosine-5\u2032-phosphosulfate preparation using Nudix hydrolase NudJ","volume":"99","author":"Bao","year":"2015","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.carres.2012.07.013","article-title":"Production of intracellular heparosan and derived oligosaccharides by lyase expression in metabolically engineered E. coli K-12","volume":"360","author":"Barreteau","year":"2012","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0080","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1055\/s-0038-1651034","article-title":"The effect of calcium chloride on anti-Xa activity of heparin and its molecular weight fractions","volume":"62","author":"Barrowcliffe","year":"1989","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0085","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/j.drudis.2020.09.011","article-title":"Advances in the preparation and synthesis of heparin and related products","volume":"25","author":"Baytas","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biotechadv.2024.108456_bb0090","doi-asserted-by":"crossref","first-page":"25556","DOI":"10.1074\/jbc.273.40.25556","article-title":"Heparan sulfate\/heparin N-deacetylase\/N-sulfotransferase. The N-sulfotransferase activity domain is at the carboxyl half of the holoenzyme","volume":"273","author":"Berninsone","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0095","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.copbio.2013.02.019","article-title":"Pathway and protein engineering approaches to produce novel and commodity small molecules","volume":"24","author":"Bhan","year":"2013","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0100","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.carbpol.2014.10.054","article-title":"Combinatorial one-pot chemoenzymatic synthesis of heparin","volume":"122","author":"Bhaskar","year":"2015","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0105","first-page":"71","article-title":"Investigating the molecular basis for the virulence of Escherichia coli K5 by nuclear magnetic resonance analysis of the capsule polysaccharide","volume":"17","author":"Blundell","year":"2009","journal-title":"J. Mol. Microbiol. Biotechnol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0110","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00284-005-4466-0","article-title":"Biochemical characterization of the pneumococcal glucose 1-phosphate uridylyltransferase (GalU) essential for capsule biosynthesis","volume":"51","author":"Bonofiglio","year":"2005","journal-title":"Curr. Microbiol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0115","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1574-6968.1993.tb06527.x","article-title":"Synthesis of the K5 (group II) capsular polysaccharide in transport-deficient recombinant Escherichia coli","volume":"113","author":"Bronner","year":"1993","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0120","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00018-014-1743-8","article-title":"Of von Willebrand factor and platelets","volume":"72","author":"Bryckaert","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0125","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.1021\/jo000266o","article-title":"Regeneration of PAPS for the enzymatic synthesis of sulfated oligosaccharides","volume":"65","author":"Burkart","year":"2000","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0130","doi-asserted-by":"crossref","first-page":"103S","DOI":"10.1592\/phco.24.12.103S.36109","article-title":"Heparin overview and issues","volume":"24","author":"Bussey","year":"2004","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.biotechadv.2024.108456_bb0135","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1021\/ar0400239","article-title":"Nucleotide sugar transporters of the Golgi apparatus: from basic science to diseases","volume":"39","author":"Caffaro","year":"2006","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0140","series-title":"Heparin - a Century of Progress. Handbook of Experimental Pharmacology","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/978-3-642-23056-1_2","article-title":"Heparin biosynthesis","volume":"vol. 207","author":"Carlsson","year":"2012"},{"key":"10.1016\/j.biotechadv.2024.108456_bb0145","series-title":"StatPearls","article-title":"Biochemistry, Glycosaminoglycans","author":"Casale","year":"2023"},{"key":"10.1016\/j.biotechadv.2024.108456_bb0150","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/jth.13312","article-title":"The design and synthesis of new synthetic low-molecular-weight heparins","volume":"14","author":"Chandarajoti","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0155","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1016\/j.bmc.2012.11.053","article-title":"Use of biosynthetic enzymes in heparin and heparan sulfate synthesis","volume":"21","author":"Chappell","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0160","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1007\/s00253-009-2214-2","article-title":"In vitro synthesis of heparosan using recombinant Pasteurella multocida heparosan synthase PmHS2","volume":"85","author":"Chavaroche","year":"2010","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0165","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.carbpol.2012.04.046","article-title":"Production methods for heparosan, a precursor of heparin and heparan sulfate","volume":"93","author":"Chavaroche","year":"2013","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0170","doi-asserted-by":"crossref","first-page":"42817","DOI":"10.1074\/jbc.M504338200","article-title":"Enzymatic redesigning of biologically active heparan sulfate","volume":"280","author":"Chen","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12934-015-0389-z","article-title":"The sweet branch of metabolic engineering: cherry-picking the low-hanging sugary fruits","volume":"14","author":"Chen","year":"2015","journal-title":"Microb. Cell Factories"},{"key":"10.1016\/j.biotechadv.2024.108456_bb0180","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00449-016-1732-4","article-title":"Metabolic engineering of Bacillus subtilis for biosynthesis of heparosan using heparosan synthase from Pasteurella multocida, PmHS1","volume":"40","author":"Chen","year":"2017","journal-title":"Bioprocess Biosyst. Eng."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0185","doi-asserted-by":"crossref","first-page":"10815","DOI":"10.1039\/c1cc14034e","article-title":"One-pot three-enzyme synthesis of UDP-GlcNAc derivatives","volume":"47","author":"Chen","year":"2011","journal-title":"Chem. Commun."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0190","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/s41592-018-0086-z","article-title":"The GAGOme: a cell-based library of displayed glycosaminoglycans","volume":"15","author":"Chen","year":"2018","journal-title":"Nat. Methods"},{"key":"10.1016\/j.biotechadv.2024.108456_bb0195","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/0006-291X(83)90550-8","article-title":"Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity","volume":"116","author":"Choay","year":"1983","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0200","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1007\/s00253-009-2261-8","article-title":"Production of capsular polysaccharide from Escherichia coli K4 for biotechnological applications","volume":"85","author":"Cimini","year":"2010","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0205","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1128\/JB.182.13.3761-3766.2000","article-title":"Cloning, expression, and purification of the K5 capsular polysaccharide lyase (KflA) from coliphage K5A: evidence for two distinct K5 lyase enzymes","volume":"182","author":"Clarke","year":"2000","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0210","series-title":"Heparin-binding proteins","author":"Conrad","year":"1997"},{"key":"10.1016\/j.biotechadv.2024.108456_bb0215","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.thromres.2011.11.008","article-title":"Old and new heparins","volume":"129","author":"Cosmi","year":"2012","journal-title":"Thromb. Res."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0220","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/genomeA.00047-13","article-title":"Draft genome sequence of Escherichia coli strain Nissle 1917 (serovar O6: K5: H1)","volume":"1","author":"Cress","year":"2013","journal-title":"Genome Announc."},{"issue":"4","key":"10.1016\/j.biotechadv.2024.108456_bb0225","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/1574-6976.12056","article-title":"Masquerading microbial pathogens: capsular polysaccharides mimic host-tissue molecules","volume":"38","author":"Cress","year":"2014","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0230","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.copbio.2015.09.007","article-title":"Sensitive cells: enabling tools for static and dynamic control of microbial metabolic pathways","volume":"36","author":"Cress","year":"2015","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0235","doi-asserted-by":"crossref","first-page":"5962","DOI":"10.1002\/anie.201900768","article-title":"Heavy heparin: a stable isotope-enriched, chemoenzymatically-synthesized, poly-component drug","volume":"58","author":"Cress","year":"2019","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0240","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/glycob\/cwad021","article-title":"Characterization and expression of highly active recombinant human glucuronyl C5-epimerase in mammalian cells","volume":"33","author":"Cui","year":"2023","journal-title":"Glycobiol"},{"key":"10.1016\/j.biotechadv.2024.108456_bb0245","doi-asserted-by":"crossref","first-page":"37308","DOI":"10.1074\/jbc.M113.519033","article-title":"Bioengineered Chinese hamster ovary cells with Golgi-targeted 3-O-sulfotransferase-1 biosynthesize heparan sulfate with an antithrombin-binding site","volume":"288","author":"Datta","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0250","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/bit.24841","article-title":"An\u2019omics approach towards CHO cell engineering","volume":"110","author":"Datta","year":"2013","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0255","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00253-020-11079-9","article-title":"High density fermentation of probiotic E. Coli Nissle 1917 towards heparosan production, characterization, and modification","volume":"105","author":"Datta","year":"2021","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0260","doi-asserted-by":"crossref","DOI":"10.1002\/biot.202000336","article-title":"Heparosan chain characterization: sequential depolymerization of E. Coli K5 heparosan by a bacterial eliminase heparin lyase III and a bacterial hydrolase heparanase Bp to prepare defined oligomers","volume":"16","author":"Datta","year":"2021","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0265","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00253-011-3801-6","article-title":"Glycosaminoglycan polysaccharide biosynthesis and production: today and tomorrow","volume":"94","author":"DeAngelis","year":"2012","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0270","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1517\/17425247.2015.978282","article-title":"Heparosan, a promising \u2018naturally good\u2019 polymeric conjugating vehicle for delivery of injectable therapeutics","volume":"12","author":"DeAngelis","year":"2015","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0275","doi-asserted-by":"crossref","first-page":"7209","DOI":"10.1074\/jbc.M112130200","article-title":"Identification and molecular cloning of a heparosan synthase from Pasteurella multocida type D","volume":"277","author":"DeAngelis","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0280","doi-asserted-by":"crossref","first-page":"8529","DOI":"10.1128\/JB.186.24.8529-8532.2004","article-title":"Identification of a distinct, cryptic heparosan synthase from Pasteurella multocida types A, D, and F","volume":"186","author":"DeAngelis","year":"2004","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0285","doi-asserted-by":"crossref","first-page":"6760","DOI":"10.1073\/pnas.1818333116","article-title":"Substrate binding mode and catalytic mechanism of human heparan sulfate D-glucuronyl C5 epimerase","volume":"116","author":"Debarnot","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biotechadv.2024.108456_bb0290","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ymben.2021.07.012","article-title":"Synergistic improvement of N-acetylglucosamine production by engineering transcription factors and balancing redox cofactors","volume":"67","author":"Deng","year":"2021","journal-title":"Metab. Eng."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0295","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1038\/s41467-024-48193-5","article-title":"Biosynthetic production of anticoagulant heparin polysaccharides through metabolic and sulfotransferases engineering strategies","volume":"15","author":"Deng","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0300","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.1021\/acs.orglett.0c01386","article-title":"Programmable one-pot synthesis of heparin pentasaccharide fondaparinux","volume":"22","author":"Dey","year":"2020","journal-title":"Org. Lett."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0305","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1016\/j.bmcl.2017.04.013","article-title":"Efficient and practical synthesis of Fondaparinux","volume":"27","author":"Ding","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0310","doi-asserted-by":"crossref","first-page":"20427","DOI":"10.1074\/jbc.M115.664409","article-title":"Role of deacetylase activity of N-deacetylase\/N-sulfotransferase 1 in forming N-sulfated domain in heparan sulfate","volume":"290","author":"Dou","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biotechadv.2024.108456_bib1373","doi-asserted-by":"crossref","first-page":"2315586121","DOI":"10.1073\/pnas.2315586121","article-title":"Synthesis of bioengineered heparin chemically and biologically similar to porcine-derived products and convertible to low MW heparin","volume":"121","author":"Douaisi","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0320","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/00005768-200005000-00007","article-title":"Blood hemostasis in exercise and training","volume":"32","author":"El-Sayed","year":"2000","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0325","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241814101","article-title":"The glycosaminoglycan side chains and modular core proteins of heparan sulphate proteoglycans and the varied ways they provide tissue protection by regulating physiological processes and cellular behaviour","volume":"24","author":"Farrugia","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0330","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.3390\/molecules20034254","article-title":"Can we produce heparin\/heparan sulfate biomimetics using \u201cmother-nature\u201d as the gold standard?","volume":"20","author":"Farrugia","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.biotechadv.2024.108456_bb0335","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/23488","article-title":"Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme","volume":"400","author":"Forsberg","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.biotechadv.2024.108456_bb0340","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.addr.2015.11.002","article-title":"Bioengineered heparins and heparan sulfates","volume":"97","author":"Fu","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0345","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/glycob\/cwt108","article-title":"Bioengineering murine mastocytoma cells to produce anticoagulant heparin","volume":"24","author":"Gasimli","year":"2014","journal-title":"Glycobiol"},{"key":"10.1016\/j.biotechadv.2024.108456_bb0350","doi-asserted-by":"crossref","first-page":"20441","DOI":"10.1074\/jbc.R800064200","article-title":"Exosite determinants of serpin specificity","volume":"284","author":"Gettins","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0355","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1021\/cr950031q","article-title":"Recent advances in the chemoenzymatic synthesis of carbohydrates and carbohydrate mimetics","volume":"96","author":"Gijsen","year":"1996","journal-title":"Chem. Rev."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0360","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3389\/fmed.2018.00341","article-title":"Recombinant heparin\u2014new opportunities","volume":"5","author":"Glass","year":"2018","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.biotechadv.2024.108456_bb0365","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cbpa.2020.09.008","article-title":"Current state on the enzymatic synthesis of glycosaminoglycans","volume":"61","author":"Gottschalk","year":"2021","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0370","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20225664","article-title":"Key factors for a one-pot enzyme cascade synthesis of high molecular weight hyaluronic acid","volume":"20","author":"Gottschalk","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0375","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1515\/BC.2006.139","article-title":"Heparin modulation of human plasma kallikrein on different substrates and inhibitors","volume":"387","author":"Gozzo","year":"2006","journal-title":"Biol. Chem."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0380","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-3-642-23056-1_3","article-title":"The anticoagulant and antithrombotic mechanisms of heparin. Heparin-a century of progress","volume":"207","author":"Gray","year":"2012","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0385","doi-asserted-by":"crossref","first-page":"710","DOI":"10.2174\/0929866524666170724113452","article-title":"The enzymatic degradation of heparan sulfate","volume":"24","author":"Griffin","year":"2017","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0390","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1042\/bst0270507","article-title":"Biosynthesis of the Escherichia coli K5 capsular polysaccharide","volume":"27","author":"Griffiths","year":"1999","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0395","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nbt1407","article-title":"Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events","volume":"26","author":"Guerrini","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0400","first-page":"2012","article-title":"Metabolic engineering of Lactococcus lactis for the production of heparosan","author":"Guhan","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.biotechadv.2024.108456_bb0410","doi-asserted-by":"crossref","first-page":"14631","DOI":"10.1074\/jbc.M313760200","article-title":"Irreversible glucuronyl C5- epimerization in the biosynthesis of heparan sulfate","volume":"279","author":"Hagner-McWhirter","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0415","doi-asserted-by":"crossref","first-page":"27886","DOI":"10.1074\/jbc.M114.590752","article-title":"A novel eliminase from a marine bacterium that degrades hyaluronan and chondroitin sulfate","volume":"289","author":"Han","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0420","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/bs.pmbts.2019.02.003","article-title":"Low molecular weight heparins and their clinical applications","volume":"163","author":"Hao","year":"2019","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.pmbts.2019.02.002","article-title":"Heparin: an essential drug for modern medicine","volume":"163","author":"Hao","year":"2019","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0430","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.carbpol.2011.06.042","article-title":"Controlled photochemical depolymerization of K5 heparosan, a bioengineered heparin precursor","volume":"86","author":"Higashi","year":"2011","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0435","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.carbpol.2011.09.087","article-title":"Photochemical preparation of a novel low molecular weight heparin","volume":"87","author":"Higashi","year":"2012","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0440","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1161\/01.CIR.89.3.1449","article-title":"Guide to anticoagulant therapy. Part 1: heparin. American Heart Association","volume":"89","author":"Hirsh","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.biotechadv.2024.108456_bb0445","doi-asserted-by":"crossref","first-page":"27311","DOI":"10.1016\/S0021-9258(19)61512-7","article-title":"Identification that KfiA, a protein essential for the biosynthesis of the Escherichia coli K5 capsular polysaccharide, is an \u03b1-UDP-GlcNac glycosyltransferase: the formation of a membrane-associated K5 biosynthetic complex requires KfiA, KfiB, and KfiC","volume":"275","author":"Hodson","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0450","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0268-960X(03)90000-2","article-title":"A cell-based model of coagulation and the role of factor VIIa","volume":"17","author":"Hoffman","year":"2003","journal-title":"Blood Rev."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0455","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1055\/s-0037-1615947","article-title":"A cell-based model of hemostasis","volume":"85","author":"Hoffman","year":"2001","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0460","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1124\/pharmrev.122.000684","article-title":"Pharmacology of heparin and related drugs: An update","volume":"75","author":"Hogwood","year":"2023","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0465","doi-asserted-by":"crossref","first-page":"5670","DOI":"10.1016\/S0021-9258(18)91066-5","article-title":"Involvement of heparin chain length in the heparin-catalyzed inhibition of thrombin by antithrombin III","volume":"259","author":"Hoylaerts","year":"1984","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.119829","article-title":"Biosynthesis of non-sulfated high-molecular-weight glycosaminoglycans and specific-sized oligosaccharides","volume":"295","author":"Hu","year":"2022","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.enzmictec.2022.110038","article-title":"Engineering the probiotic bacterium Escherichia coli Nissle 1917 as an efficient cell factory for heparosan biosynthesis","volume":"158","author":"Hu","year":"2022","journal-title":"Enzym. Microb. Technol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0480","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/23481","article-title":"Heparin is essential for the storage of specific granule proteases in mast cells","volume":"400","author":"Humphries","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.biotechadv.2024.108456_bb0485","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1046\/j.1538-7836.2003.00305.x","article-title":"Mechanisms of glycosaminoglycan activation of the serpins in hemostasis","volume":"1","author":"Huntington","year":"2003","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0490","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.tibs.2006.06.005","article-title":"Shape-shifting serpins\u2013advantages of a mobile mechanism","volume":"31","author":"Huntington","year":"2006","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0495","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1538-7836.2011.04360.x","article-title":"Serpin structure, function and dysfunction","volume":"9","author":"Huntington","year":"2011","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0500","doi-asserted-by":"crossref","first-page":"34049","DOI":"10.1074\/jbc.M114.611707","article-title":"Conformational activation of antithrombin by heparin involves an altered exosite interaction with protease","volume":"289","author":"Izaguirre","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0505","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1186\/s12967-020-02624-1","article-title":"Heparanase and the hallmarks of cancer","volume":"18","author":"Jayatilleke","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0510","doi-asserted-by":"crossref","first-page":"13846","DOI":"10.1039\/C5CC05222J","article-title":"Synthetic heparan sulfate dodecasaccharides reveal single sulfation site interconverts CXCL8 and CXCL12 chemokine biology","volume":"51","author":"Jayson","year":"2015","journal-title":"Chem. Commun."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0515","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3389\/fmed.2018.00360","article-title":"Bovine mucosal heparins are comparable to porcine mucosal heparin at USP potency adjusted levels","volume":"5","author":"Jeske","year":"2019","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.biotechadv.2024.108456_bb0520","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.synbio.2022.10.002","article-title":"Heparin mimetics as potential intervention for COVID-19 and their bio-manufacturing","volume":"8","author":"Jiang","year":"2023","journal-title":"Synth. Syst. Biotechnol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0525","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.carbpol.2015.12.065","article-title":"Efficient biosynthesis of polysaccharides chondroitin and heparosan by metabolically engineered Bacillus subtilis","volume":"140","author":"Jin","year":"2016","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0530","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1073\/pnas.0910144107","article-title":"Molecular basis of factor IXa recognition by heparin-activated antithrombin revealed by a 1.7-\u00c5 structure of the ternary complex","volume":"107","author":"Johnson","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biotechadv.2024.108456_bb0535","series-title":"Methods Enzymol","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/bs.mie.2016.02.010","article-title":"Optimizing metabolic pathways for the improved production of natural products","author":"Jones","year":"2016"},{"key":"10.1016\/j.biotechadv.2024.108456_bb0540","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.copbio.2014.11.013","article-title":"Metabolic pathway balancing and its role in the production of biofuels and chemicals","volume":"33","author":"Jones","year":"2015","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0545","doi-asserted-by":"crossref","first-page":"33192","DOI":"10.1074\/jbc.M606897200","article-title":"Functional characterization of PmHS1, a Pasteurella multocida heparosan synthase","volume":"281","author":"Kane","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0550","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.tibtech.2018.03.010","article-title":"Bio-based strategies for producing glycosaminoglycans and their oligosaccharides","volume":"36","author":"Kang","year":"2018","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0555","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abl6026","article-title":"Dissecting structure-function of 3-O-sulfated heparin and engineered heparan sulfates","volume":"7","author":"Karlsson","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0560","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.2174\/0929867033456891","article-title":"Recent chemical and enzymatic approaches to the synthesis of glycosaminoglycan oligosaccharides","volume":"10","author":"Karst","year":"2003","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0565","doi-asserted-by":"crossref","first-page":"12684","DOI":"10.1074\/jbc.M109.094490","article-title":"A new arylsulfate sulfotransferase involved in liponucleoside antibiotic biosynthesis in streptomycetes","volume":"285","author":"Kaysser","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"330","key":"10.1016\/j.biotechadv.2024.108456_bb0570","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1126\/science.1193990","article-title":"Manufacturing molecules through metabolic engineering","volume":"1979","author":"Keasling","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.biotechadv.2024.108456_bb0580","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cbi.2016.05.021","article-title":"Sulfation pathways in plants","volume":"259","author":"Koprivova","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0585","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1042\/BCJ20210415","article-title":"Decoding the consecutive lysosomal degradation of 3-O-sulfate containing heparan sulfate by arylsulfatase G (ARSG)","volume":"478","author":"Kowalewski","year":"2021","journal-title":"Biochem. J."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0590","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1369\/0022155412464972","article-title":"Heparan sulfate biosynthesis: regulation and variability","volume":"60","author":"Kreuger","year":"2012","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0595","doi-asserted-by":"crossref","first-page":"12424","DOI":"10.1021\/ja036737g","article-title":"Rapid two-step synthesis of mitrin from heparosan: a replacement for heparin","volume":"125","author":"Kuberan","year":"2003","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0600","doi-asserted-by":"crossref","first-page":"52613","DOI":"10.1074\/jbc.M305029200","article-title":"Chemoenzymatic synthesis of classical and non-classical anticoagulant heparan sulfate polysaccharides","volume":"278","author":"Kuberan","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0605","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/nbt885","article-title":"Enzymatic synthesis of antithrombin III\u2013binding heparan sulfate pentasaccharide","volume":"21","author":"Kuberan","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0610","doi-asserted-by":"crossref","DOI":"10.1038\/srep11601","article-title":"A single-dose of oral nattokinase potentiates thrombolysis and anti-coagulation profiles","volume":"5","author":"Kurosawa","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0615","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1042\/bj2750151","article-title":"Biosynthesis of heparin. Use of Escherichia coli K5 capsular polysaccharide as a model substrate in enzymic polymer-modification reactions","volume":"J.275","author":"Kusche","year":"1991","journal-title":"Biochem"},{"key":"10.1016\/j.biotechadv.2024.108456_bb0620","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1146\/annurev.biochem.76.061005.092322","article-title":"Glycosyltransferases: structures, functions, and mechanisms","volume":"77","author":"Lairson","year":"2008","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0625","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/glycob\/cwx070","article-title":"Heparosan-coated liposomes for drug delivery","volume":"27","author":"Lane","year":"2017","journal-title":"Glycobiol"},{"key":"10.1016\/j.biotechadv.2024.108456_bb0630","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/adsc.201500916","article-title":"Towards keratan sulfate\u2013chemoenzymatic cascade synthesis of sulfated N-acetyllactosamine (LacNAc) glycan oligomers","volume":"358","author":"Lange","year":"2016","journal-title":"Adv. Synth. Catal."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0635","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.1128\/jb.178.24.7260-7264.1996","article-title":"N-acetyl-heparosan lyase of Escherichia coli K5: gene cloning and expression","volume":"178","author":"Legoux","year":"1996","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0640","doi-asserted-by":"crossref","first-page":"10355","DOI":"10.1007\/s00253-016-7745-8","article-title":"Chaperone-assisted expression of KfiC glucuronyltransferase from Escherichia coli K5 leads to heparosan production in Escherichia coli BL21 in absence of the stabilisator KfiB","volume":"100","author":"Leroux","year":"2016","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0645","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1016\/S0021-9258(18)69222-1","article-title":"The sulfate activation locus of Escherichia coli K12: cloning, genetic, and enzymatic characterization","volume":"263","author":"Leyh","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0650","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ijbiomac.2020.02.214","article-title":"Chemical, enzymatic and biological synthesis of hyaluronic acids","volume":"152","author":"Li","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0655","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S1877-1173(10)93004-4","article-title":"Glucuronyl C5-epimerase an enzyme converting glucuronic acid to iduronic acid in heparan sulfate\/heparin biosynthesis","volume":"93","author":"Li","year":"2010","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0660","doi-asserted-by":"crossref","first-page":"20069","DOI":"10.1074\/jbc.M011783200","article-title":"Characterization of the D-glucuronyl C5-epimerase involved in the biosynthesis of heparin and heparan sulfate","volume":"276","author":"Li","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0665","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/med.21263","article-title":"Heparosan-derived heparan sulfate\/heparin-like compounds: one kind of potential therapeutic agents","volume":"33","author":"Li","year":"2013","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0670","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1007\/s10529-021-03156-4","article-title":"The construction of a dual-functional strain that produces both polysaccharides and sulfotransferases","volume":"43","author":"Li","year":"2021","journal-title":"Biotechnol. Lett."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0675","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.bbagen.2017.11.016","article-title":"Characterization of heparan sulfate N-deacetylase\/N-sulfotransferase isoform 4 using synthetic oligosaccharide substrates","volume":"1862","author":"Li","year":"2018","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0680","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.addr.2015.10.017","article-title":"Hyaluronan as a therapeutic target in human diseases","volume":"97","author":"Liang","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0685","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1042\/bj2540571","article-title":"Biosynthesis of heparin. Modulation of polysaccharide chain length in a cell-free system","volume":"254","author":"Lidholt","year":"1988","journal-title":"Biochem. J."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0690","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2019.113419","article-title":"High-throughput method for in process monitoring of 3-O-sulfotransferase catalyzed sulfonation in bioengineered heparin synthesis","volume":"586","author":"Lin","year":"2019","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0695","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0304-4165(01)00117-9","article-title":"Antithrombin binding of low molecular weight heparins and inhibition of factor Xa","volume":"1526","author":"Lin","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biotechadv.2024.108456_bb0700","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1021\/jm049812m","article-title":"Generation of \u201cNeoheparin\u201d from E. Coli K5 capsular polysaccharide","volume":"48","author":"Lindahl","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0705","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1021\/jm030176m","article-title":"2003 Claude S. Hudson award address in carbohydrate chemistry. Heparin: structure and activity","volume":"46","author":"Linhardt","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0710","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.coph.2011.12.002","article-title":"Synthetic heparin","volume":"12","author":"Linhardt","year":"2012","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0715","doi-asserted-by":"crossref","first-page":"6938","DOI":"10.1002\/anie.202016072","article-title":"The total synthesis of chondrochloren a","volume":"60","author":"Linne","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0720","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1039\/b819896a","article-title":"Lessons learned from the contamination of heparin","volume":"26","author":"Liu","year":"2009","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0725","article-title":"Chemoenzymatic synthesis of heparan sulfate and heparin oligosaccharides and NMR analysis: paving the way to a diverse library for glycobiologists","volume":"31","author":"Liu","year":"2014","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0730","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.tim.2022.11.003","article-title":"Microbial synthesis of glycosaminoglycans and their oligosaccharides","volume":"31","author":"Liu","year":"2023","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0735","doi-asserted-by":"crossref","first-page":"34240","DOI":"10.1074\/jbc.M110.159152","article-title":"Chemoenzymatic design of heparan sulfate oligosaccharides","volume":"285","author":"Liu","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0740","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s00449-012-0708-2","article-title":"Effects of carbon sources and feeding strategies on heparosan production by Escherichia coli K5","volume":"35","author":"Liu","year":"2012","journal-title":"Bioprocess Biosyst. Eng."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0745","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4161\/bioe.29388","article-title":"Bioengineered heparin: is there a future for this form of the successful therapeutic?","volume":"5","author":"Lord","year":"2014","journal-title":"Bioengineered"},{"key":"10.1016\/j.biotechadv.2024.108456_bb0750","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ymben.2016.07.006","article-title":"Bioengineered human heparin with anticoagulant activity","volume":"38","author":"Lord","year":"2016","journal-title":"Metab. Eng."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0755","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.1021\/ol062464t","article-title":"Synthesis of 48 disaccharide building blocks for the assembly of a heparin and heparan sulfate oligosaccharide library","volume":"8","author":"Lu","year":"2006","journal-title":"Org. Lett."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0760","doi-asserted-by":"crossref","first-page":"5438","DOI":"10.1002\/ange.201800387","article-title":"Controlled chemoenzymatic synthesis of heparan sulfate oligosaccharides","volume":"130","author":"Lu","year":"2018","journal-title":"Angew. Chem."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0765","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1021\/bi401725j","article-title":"Structural and mechanistic insights into the PAPS-independent sulfotransfer catalyzed by bacterial aryl sulfotransferase and the role of the DsbL\/DsbI system in its folding","volume":"53","author":"Malojcic","year":"2014","journal-title":"Biochem"},{"key":"10.1016\/j.biotechadv.2024.108456_bb0770","doi-asserted-by":"crossref","first-page":"4746","DOI":"10.1182\/blood-2005-11-4674","article-title":"Cellular localization and trafficking of tissue factor","volume":"107","author":"Mandal","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.biotechadv.2024.108456_bb0780","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1023\/B:BILE.0000015473.89280.ce","article-title":"Preliminary characterisation of an Escherichia coli K5 lyase-deficient strain producing the K5 polysaccharide","volume":"26","author":"Manzoni","year":"2004","journal-title":"Biotechnol. Lett."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0785","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.thromres.2010.11.008","article-title":"Heparin affinity of factor VIIa: implications on the physiological inhibition by antithrombin and clearance of recombinant factor VIIa","volume":"127","author":"Mart\u00ednez-Mart\u00ednez","year":"2011","journal-title":"Thromb. Res."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0790","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4155\/fmc.11.185","article-title":"Chemoenzymatic synthesis of the next generation of ultralow MW heparin therapeutics","volume":"4","author":"Masuko","year":"2012","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0795","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1021\/jo202322k","article-title":"Chemoenzymatic synthesis of uridine diphosphate-GlcNAc and uridine diphosphate-GalNAc analogs for the preparation of unnatural glycosaminoglycans","volume":"77","author":"Masuko","year":"2012","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0800","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(19)33135-6","article-title":"Running thin: implications of a heparin shortage","volume":"395","author":"McCarthy","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.biotechadv.2024.108456_bb0805","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1152\/ajplegacy.1916.41.2.250","article-title":"The thromboplastic action of cephalin","volume":"41","author":"McLean","year":"1916","journal-title":"Am. J. Physiol. Legacy."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0815","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1365-2958.2005.05010.x","article-title":"The cell surface expression of group 2 capsular polysaccharides in Escherichia coli: the role of KpsD, RhsA and a multi-protein complex at the pole of the cell","volume":"59","author":"McNulty","year":"2006","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0820","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3390\/molecules22061025","article-title":"From farm to pharma: an overview of industrial heparin manufacturing methods","volume":"22","author":"van der Meer","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.biotechadv.2024.108456_bb0825","doi-asserted-by":"crossref","first-page":"8193","DOI":"10.1021\/acs.chemrev.6b00010","article-title":"Chemical synthesis of glycosaminoglycans","volume":"116","author":"Mende","year":"2016","journal-title":"Chem. Rev."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0830","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1574-6976.2008.00139.x","article-title":"Engineering prokaryotic gene circuits","volume":"33","author":"Michalodimitrakis","year":"2008","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0840","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1099924","article-title":"Design of a biocatalytic cascade for the enzymatic sulfation of unsulfated chondroitin with in situ generation of PAPS","volume":"11","author":"Monterrey","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0850","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048632","article-title":"On the specificity of heparin\/heparan sulfate binding to proteins. Anion-binding sites on antithrombin and thrombin are fundamentally different","volume":"7","author":"Mosier","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biotechadv.2024.108456_bb0855","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1124\/pr.115.011247","article-title":"Pharmacology of heparin and related drugs","volume":"68","author":"Mulloy","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0860","doi-asserted-by":"crossref","first-page":"6113","DOI":"10.1021\/acscatal.0c01231","article-title":"Engineer P. multocida heparosan synthase 2 (PmHS2) for size-controlled synthesis of longer heparosan oligosaccharides","volume":"10","author":"Na","year":"2020","journal-title":"ACS Catal."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0865","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1055\/s-2001-17954","article-title":"Toward a biotechnological heparin through combined chemical and enzymatic modification of the Escherichia coli K5 polysaccharide","author":"Naggi","year":"2001","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.biotechadv.2024.108456_bib1372","doi-asserted-by":"crossref","first-page":"2000110","DOI":"10.1002\/mabi.202000110","article-title":"Sulfonated RAFT copolymers as heparin mimetics: synthesis, reactivity ratios, and anticoagulant activity","volume":"20","author":"Nahain","year":"2020","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0870","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijbiomac.2020.05.159","article-title":"Production and characterization of low molecular weight heparosan in bacillus megaterium using Escherichia coli K5 glycosyltransferases","volume":"160","author":"Nehru","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0875","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1007\/s12010-021-03541-9","article-title":"Application of dual promoter expression system for the enhanced heparosan production in bacillus megaterium","volume":"193","author":"Nehru","year":"2021","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0880","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1126\/science.361.6404.741","article-title":"Arrival of deadly pig disease could spell disaster for China","volume":"361","author":"Normile","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.biotechadv.2024.108456_bb0885","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/ph9030038","article-title":"Heparin: past, present, and future","volume":"9","author":"Oduah","year":"2016","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.biotechadv.2024.108456_bb0890","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-2007-1002750","article-title":"Mechanisms of action of heparin: applications to the development of derivatives of heparin and heparinoids with antithrombotic properties, in: seminars in thrombosis and hemostasis","volume":"14","author":"Ofosu","year":"1988","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0895","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1160\/TH04-06-0384","article-title":"Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems comparison with heparin and low-molecular-weight heparin","volume":"92","author":"Olson","year":"2004","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0900","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.2741\/4462","article-title":"Heparin and anticoagulation","volume":"21","author":"Onishi","year":"2016","journal-title":"Front. Biosci. (Landmark Ed)"},{"key":"10.1016\/j.biotechadv.2024.108456_bb0905","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0034-5288(93)90005-Z","article-title":"Capsular hyaluronic acid in Pasteurella multocida type a and its counterpart in type D","volume":"54","author":"Pandit","year":"1993","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0910","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s00216-012-5944-4","article-title":"Recent advances in sulfotransferase enzyme activity assays","volume":"403","author":"Paul","year":"2012","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0915","doi-asserted-by":"crossref","first-page":"18750","DOI":"10.1002\/ange.201908805","article-title":"Expedient synthesis of core disaccharide building blocks from natural polysaccharides for heparan sulfate oligosaccharide assembly","volume":"131","author":"Pawar","year":"2019","journal-title":"Angew. Chem."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0920","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ultsonch.2006.03.010","article-title":"Ultrasonic depolymerization of an exopolysaccharide produced by a bacterium isolated from a deep-sea hydrothermal vent polychaete annelid","volume":"14","author":"Petit","year":"2007","journal-title":"Ultrason. Sonochem."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0925","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1365-2958.1995.mmi_17040611.x","article-title":"Region 2 of the Escherichia coli K5 capsule gene cluster encoding proteins for the biosynthesis of the K5 polysaccharide","volume":"17","author":"Petit","year":"1995","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0930","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1002\/anie.200300640","article-title":"A synthetic antithrombin III binding pentasaccharide is now a drug! What comes next?","volume":"43","author":"Petitou","year":"2004","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0935","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/18877","article-title":"Synthesis of thrombin-inhibiting heparin mimetics without side effects","volume":"398","author":"Petitou","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.biotechadv.2024.108456_bb0940","article-title":"Role of von Willebrand factor in the haemostasis","volume":"9","author":"Peyvandi","year":"2011","journal-title":"Blood Transfus."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0945","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ymben.2006.11.002","article-title":"Balancing a heterologous mevalonate pathway for improved isoprenoid production in Escherichia coli","volume":"9","author":"Pitera","year":"2007","journal-title":"Metab. Eng."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0950","doi-asserted-by":"crossref","first-page":"12795","DOI":"10.1021\/ja073098r","article-title":"Anomeric reactivity-based one-pot synthesis of heparin-like oligosaccharides","volume":"129","author":"Polat","year":"2007","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0955","doi-asserted-by":"crossref","first-page":"6989","DOI":"10.1007\/s00253-019-09987-6","article-title":"Enhancement of acetyl-CoA by acetate co-utilization in recombinant Lactococcus lactis cultures enables the production of high molecular weight hyaluronic acid","volume":"103","author":"Puvendran","year":"2019","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0960","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2020.121270","article-title":"Recent advances in biotechnology for heparin and heparan sulfate analysis","volume":"219","author":"Qiao","year":"2020","journal-title":"Talanta"},{"key":"10.1016\/j.biotechadv.2024.108456_bb0965","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1074\/jbc.M114.602201","article-title":"Structural and functional study of D-glucuronyl C5-epimerase","volume":"290","author":"Qin","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0970","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/s41592-018-0189-6","article-title":"A mutant-cell library for systematic analysis of heparan sulfate structure\u2013function relationships","volume":"15","author":"Qiu","year":"2018","journal-title":"Nat. Methods"},{"key":"10.1016\/j.biotechadv.2024.108456_bb0975","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111561","article-title":"Pharmacological and clinical application of heparin progress: An essential drug for modern medicine","volume":"139","author":"Qiu","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0980","doi-asserted-by":"crossref","first-page":"24332","DOI":"10.1074\/jbc.M113.476440","article-title":"A novel bacterial enzyme with D-glucuronyl C5-epimerase activity","volume":"288","author":"Raedts","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0985","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2859-10-10","article-title":"High cell density cultivation of Escherichia coli K4 in a microfiltration bioreactor: a step towards improvement of chondroitin precursor production","volume":"10","author":"Restaino","year":"2011","journal-title":"Microb. Cell Factories"},{"key":"10.1016\/j.biotechadv.2024.108456_bb0990","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.1007\/s00253-012-4682-z","article-title":"High cell density cultivation of a recombinant E. Coli strain expressing a key enzyme in bioengineered heparin production","volume":"97","author":"Restaino","year":"2013","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb0995","doi-asserted-by":"crossref","first-page":"16824","DOI":"10.1074\/jbc.273.27.16824","article-title":"Calcium enhances heparin catalysis of the antithrombin-factor Xa reaction by a template mechanism: evidence that calcium alleviates Gla domain antagonism of heparin binding to factor Xa","volume":"273","author":"Rezaie","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1005","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/vr.134.8.191","article-title":"Presumptive identification of Pasteurella multocida serogroups A, D and F by capsule depolymerisation with mucopolysaccharidases","volume":"134","author":"Rimler","year":"1994","journal-title":"Vet. Rec."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1010","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1039\/C9BM00443B","article-title":"Heparosan as a potential alternative to hyaluronic acid for the design of biopolymer-based nanovectors for anticancer therapy","volume":"7","author":"Rippe","year":"2019","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1015","doi-asserted-by":"crossref","first-page":"19421","DOI":"10.1074\/jbc.M308864200","article-title":"Mechanism of collagen activation in human platelets","volume":"279","author":"Roberts","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1020","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1042\/bj20030365","article-title":"Overexpression of UDP-glucose dehydrogenase in Escherichia coli results in decreased biosynthesis of K5 polysaccharide","volume":"374","author":"Roman","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1030","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2020.129765","article-title":"Metabolic engineering of non-pathogenic Escherichia coli strains for the controlled production of low molecular weight heparosan and size-specific heparosan oligosaccharides","volume":"1865","author":"Roy","year":"2021","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.biotechadv.2024.108456_bib1371","doi-asserted-by":"crossref","first-page":"2108458118","DOI":"10.1073\/pnas.2108458118","article-title":"A reactive center loop\u2013based prediction platform to enhance the design of therapeutic SERPINs","volume":"118","author":"Sanrattana","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1035","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1093\/glycob\/cwh129","article-title":"Production of N-sulfated polysaccharides using yeast-expressed N-deacetylase\/N-sulfotransferase-1 (NDST-1)","volume":"14","author":"Sar\u0131ba\u015f","year":"2004","journal-title":"Glycobiol"},{"key":"10.1016\/j.biotechadv.2024.108456_bb1040","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.algal.2018.11.010","article-title":"Metabolic engineering of cyanobacteria for photoautotrophic production of heparosan, a pharmaceutical precursor of heparin","volume":"37","author":"Sarnaik","year":"2019","journal-title":"Algal Res."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1050","series-title":"23 Principles of Wound Healing. Mechanisms of Vascular Disease: A Reference Book for Vascular Specialists 423","author":"Schultz","year":"2011"},{"key":"10.1016\/j.biotechadv.2024.108456_bb1055","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijbiomac.2019.04.019","article-title":"Development of low molecular weight heparin by H2O2\/ascorbic acid with ultrasonic power and its anti-metastasis property","volume":"133","author":"Shen","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1060","doi-asserted-by":"crossref","first-page":"20996","DOI":"10.1074\/jbc.M112.359885","article-title":"Uncovering biphasic catalytic mode of C5-epimerase in heparan sulfate biosynthesis","volume":"287","author":"Sheng","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1065","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2024.121881","article-title":"Advancements in heparosan production through metabolic engineering and improved fermentation","author":"Sheng","year":"2024","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1075","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00216-013-7470-4","article-title":"Assays for determining heparan sulfate and heparin O-sulfotransferase activity and specificity","volume":"406","author":"Sterner","year":"2014","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1080","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1600-065X.2007.00525.x","article-title":"Protease\u2013proteoglycan complexes of mouse and human mast cells and importance of their \u03b2-tryptase\u2013heparin complexes in inflammation and innate immunity","volume":"217","author":"Stevens","year":"2007","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1085","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0167-5699(89)90272-7","article-title":"Recent advances in the cellular and molecular biology of mast cells","volume":"10","author":"Stevens","year":"1989","journal-title":"Immunol. Today"},{"key":"10.1016\/j.biotechadv.2024.108456_bb1090","doi-asserted-by":"crossref","first-page":"7465","DOI":"10.1007\/s00253-015-6821-9","article-title":"Heparin and related polysaccharides: synthesis using recombinant enzymes and metabolic engineering","volume":"99","author":"Suflita","year":"2015","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1095","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/15216540214928","article-title":"Heparin and heparan sulfate biosynthesis","volume":"54","author":"Sugahara","year":"2002","journal-title":"IUBMB Life"},{"key":"10.1016\/j.biotechadv.2024.108456_bb1100","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1074\/jbc.M109.023002","article-title":"Glucuronyltransferase activity of KfiC from Escherichia coli strain K5 requires association of KfiA","volume":"285","author":"Sugiura","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1105","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1039\/C8BM00486B","article-title":"Low molecular weight heparin-based reduction-sensitive nanoparticles for antitumor and anti-metastasis of orthotopic breast cancer","volume":"6","author":"Sun","year":"2018","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1110","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/rth2.12107","article-title":"Integrating platelet and coagulation activation in fibrin clot formation","volume":"2","author":"Swieringa","year":"2018","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1120","first-page":"24","article-title":"Advancing to recombinant heparin","author":"Thacker","year":"2021","journal-title":"Am. Pharm. Rev."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1130","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.matbio.2013.12.001","article-title":"Heparan sulfate 3-O-sulfation: a rare modification in search of a function","volume":"35","author":"Thacker","year":"2014","journal-title":"Matrix Biol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1135","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ymben.2022.01.002","article-title":"Multiplex genome editing of mammalian cells for producing recombinant heparin","volume":"70","author":"Thacker","year":"2022","journal-title":"Metab. Eng."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1140","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ddtec.2021.02.003","article-title":"Recent advances in CHO cell line development for recombinant protein production","volume":"38","author":"Tihanyi","year":"2020","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1150","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1152\/physrev.00016.2011","article-title":"New fundamentals in hemostasis","volume":"93","author":"Versteeg","year":"2013","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1155","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/jth.14372","article-title":"Imminent risk of a global shortage of heparin caused by the African swine fever afflicting the Chinese pig herd","volume":"17","author":"Vilanova","year":"2019","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1160","series-title":"Method for Producing K5 Polysaccharide. US Patent. 2008\/0032349","author":"Viskov","year":"2008"},{"key":"10.1016\/j.biotechadv.2024.108456_bb1165","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2491\/jjsth.16.623","article-title":"Heparin-induced thrombocytopenia and treatment with thrombin inhibitors","volume":"16","author":"Walenga","year":"2005","journal-title":"Japanese J. Thromb. Hemost."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1170","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.copbio.2015.11.003","article-title":"Microbial production of value-added nutraceuticals","volume":"37","author":"Wang","year":"2016","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1175","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.119818","article-title":"Heparin: An old drug for new clinical applications","volume":"295","author":"Wang","year":"2022","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1180","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbapap.2019.140301","article-title":"Chemoenzymatic synthesis of ultralow and low-molecular weight heparins","volume":"1868","author":"Wang","year":"2020","journal-title":"Biochim. Biophys. Acta, Proteins Proteomics"},{"key":"10.1016\/j.biotechadv.2024.108456_bb1185","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1038\/s41467-020-16962-7","article-title":"Eliminating the capsule-like layer to promote glucose uptake for hyaluronan production by engineered Corynebacterium glutamicum","volume":"11","author":"Wang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1190","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/bit.22898","article-title":"E. Coli K5 fermentation and the preparation of heparosan, a bioengineered heparin precursor","volume":"107","author":"Wang","year":"2010","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1195","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4161\/bbug.2.1.14201","article-title":"Escherichia coli K5 heparosan fermentation and improvement by genetic engineering","volume":"2","author":"Wang","year":"2011","journal-title":"Bioeng. Bugs."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1200","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jbiotec.2011.08.013","article-title":"Response surface optimization of the heparosan N-deacetylation in producing bioengineered heparin","volume":"156","author":"Wang","year":"2011","journal-title":"J. Biotecnol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1205","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00253-011-3231-5","article-title":"Control of the heparosan N-deacetylation leads to an improved bioengineered heparin","volume":"91","author":"Wang","year":"2011","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1210","doi-asserted-by":"crossref","first-page":"5249","DOI":"10.1021\/jacs.7b01923","article-title":"Synthesis of 3-O-sulfated oligosaccharides to understand the relationship between structures and functions of heparan sulfate","volume":"139","author":"Wang","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1215","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/978-3-319-49674-0_13","article-title":"Fibrin formation, structure and properties. Fibrous proteins: structures and mechanisms","author":"Weisel","year":"2017","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1220","doi-asserted-by":"crossref","first-page":"9311","DOI":"10.1073\/pnas.1920880117","article-title":"ZNF263 is a transcriptional regulator of heparin and heparan sulfate biosynthesis","volume":"117","author":"Weiss","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1225","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1146\/annurev.biochem.75.103004.142545","article-title":"Biosynthesis and assembly of capsular polysaccharides in Escherichia coli","volume":"75","author":"Whitfield","year":"2006","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1230","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1046\/j.1365-2958.1999.01276.x","article-title":"Structure, assembly and regulation of expression of capsules in Escherichia coli","volume":"31","author":"Whitfield","year":"1999","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1240","doi-asserted-by":"crossref","first-page":"35767","DOI":"10.1074\/jbc.M304803200","article-title":"Mechanism of catalysis of inhibition of factor IXa by antithrombin in the presence of heparin or pentasaccharide","volume":"278","author":"Wiebe","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12934-019-1187-9","article-title":"Metabolic engineering of bacillus megaterium for heparosan biosynthesis using Pasteurella multocida heparosan synthase, PmHS2","volume":"18","author":"Williams","year":"2019","journal-title":"Microb. Cell Factories"},{"key":"10.1016\/j.biotechadv.2024.108456_bb1250","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.carres.2013.05.007","article-title":"Structure, biosynthesis, and function of bacterial capsular polysaccharides synthesized by ABC transporter-dependent pathways","volume":"378","author":"Willis","year":"2013","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1255","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.vetmic.2010.03.002","article-title":"Analysis of the biosynthesis genes and chemical components of the capsule of Avibacterium paragallinarum","volume":"145","author":"Wu","year":"2010","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1260","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1002\/btpr.1777","article-title":"Transcriptional engineering of Escherichia coli K4 for fructosylated chondroitin production","volume":"29","author":"Wu","year":"2013","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1265","doi-asserted-by":"crossref","DOI":"10.1093\/jimb\/kuad012","article-title":"Improvement of the stability and catalytic efficiency of heparan sulfate N-sulfotransferase for preparing N-sulfated heparosan","volume":"50","author":"Xi","year":"2023","journal-title":"J. Ind. Microbiol. Biotechnol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1270","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jbiotec.2013.06.018","article-title":"Immobilized enzymes to convert N-sulfo, N-acetyl heparosan to a critical intermediate in the production of bioengineered heparin","volume":"167","author":"Xiong","year":"2013","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1275","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev-biochem-060713-035314","article-title":"Demystifying heparan sulfate\u2013protein interactions","volume":"83","author":"Xu","year":"2014","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1280","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.copbio.2012.08.010","article-title":"Engineering plant metabolism into microbes: from systems biology to synthetic biology","volume":"24","author":"Xu","year":"2013","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1285","doi-asserted-by":"crossref","first-page":"10405","DOI":"10.1021\/acscatal.1c02004","article-title":"Closed-loop system driven by ADP phosphorylation from pyrophosphate affords equimolar transformation of ATP to 3\u2032-phosphoadenosine-5\u2032-phosphosulfate","volume":"11","author":"Xu","year":"2021","journal-title":"ACS Catal."},{"issue":"334","key":"10.1016\/j.biotechadv.2024.108456_bb1290","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1126\/science.1207478","article-title":"Chemoenzymatic synthesis of homogeneous ultralow molecular weight heparins","volume":"1979","author":"Xu","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.biotechadv.2024.108456_bb1295","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nchembio.1459","article-title":"Homogeneous low-molecular-weight heparins with reversible anticoagulant activity","volume":"10","author":"Xu","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1300","doi-asserted-by":"crossref","first-page":"7687","DOI":"10.1128\/AEM.01814-15","article-title":"Cyclic AMP (cAMP) receptor protein-cAMP complex regulates heparosan production in Escherichia coli strain Nissle 1917","volume":"81","author":"Yan","year":"2015","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1305","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/bit.28315","article-title":"Chromosome evolution of Escherichia coli Nissle 1917 for high-level production of heparosan","volume":"120","author":"Yu","year":"2023","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1315","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ymben.2012.06.005","article-title":"Metabolic engineering of Escherichia coli BL21 for biosynthesis of heparosan, a bioengineered heparin precursor","volume":"14","author":"Zhang","year":"2012","journal-title":"Metab. Eng."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1320","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/jam.12684","article-title":"High cell density cultivation of a recombinant Escherichia coli strain expressing a 6-O-sulfotransferase for the production of bioengineered heparin","volume":"118","author":"Zhang","year":"2015","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1325","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ymben.2018.04.006","article-title":"Enhancing fructosylated chondroitin production in Escherichia coli K4 by balancing the UDP-precursors","volume":"47","author":"Zhang","year":"2018","journal-title":"Metab. Eng."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1330","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1021\/acs.accounts.9b00420","article-title":"Chemoenzymatic synthesis of glycosaminoglycans","volume":"53","author":"Zhang","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1335","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1039\/D1GC04672A","article-title":"Synthesis of bioengineered heparin by recombinant yeast Pichia pastoris","volume":"24","author":"Zhang","year":"2022","journal-title":"Green Chem."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1340","doi-asserted-by":"crossref","first-page":"12998","DOI":"10.1021\/ja8026345","article-title":"Solution structures of chemoenzymatically synthesized heparin and its precursors","volume":"130","author":"Zhang","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1345","article-title":"Overview of the current procedures in synthesis of heparin saccharides","author":"Zhao","year":"2024","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1350","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ultsonch.2018.11.016","article-title":"Preparation of low molecular weight heparin using an ultrasound-assisted Fenton-system","volume":"52","author":"Zhi","year":"2019","journal-title":"Ultrason. Sonochem."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1355","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/glycob\/cwr001","article-title":"Expression of heparan sulfate sulfotransferases in Kluyveromyces lactis and preparation of 3\u2032-phosphoadenosine-5\u2032-phosphosulfate","volume":"21","author":"Zhou","year":"2011","journal-title":"Glycobiol"},{"key":"10.1016\/j.biotechadv.2024.108456_bb1360","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/bit.26577","article-title":"A microbial\u2013enzymatic strategy for producing chondroitin sulfate glycosaminoglycans","volume":"115","author":"Zhou","year":"2018","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1365","doi-asserted-by":"crossref","first-page":"9534","DOI":"10.1021\/jacs.7b01399","article-title":"Heparan sulfate microarray reveals that heparan sulfate\u2013protein binding exhibits different ligand requirements","volume":"139","author":"Zong","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biotechadv.2024.108456_bb1370","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.cbpa.2013.10.008","article-title":"Synthetic heparin and heparan sulfate oligosaccharides and their protein interactions","volume":"17","author":"Zulueta","year":"2013","journal-title":"Curr. Opin. Chem. Biol."}],"container-title":["Biotechnology Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0734975024001502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0734975024001502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T14:28:12Z","timestamp":1741271292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0734975024001502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":260,"alternative-id":["S0734975024001502"],"URL":"https:\/\/doi.org\/10.1016\/j.biotechadv.2024.108456","relation":{},"ISSN":["0734-9750"],"issn-type":[{"value":"0734-9750","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bioengineered heparin: Advances in production technology","name":"articletitle","label":"Article Title"},{"value":"Biotechnology Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biotechadv.2024.108456","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108456"}}